The new cyclic peptide antibiotic, urukthapelstatin A, has been isolated from a culture of Thermoactinomycetaceae bacterium Mechercharimyces asporophorigenens YM11-542. The structure of urukthapelstatin A was elucidated by NMR, MS, Marfey analysis, chiral HPLC and X-ray crystal analyses.
Introduction
Urukthapelstatin A (1) is a thiopeptide antibiotic which contains three oxazoles and two thiazoles in its cyclic structure and is structurally related to mechercharstatin (former name, mechercharmycin) [1, 2] and YM-216391 [3, 4] . The fermentation, isolation and biological properties of 1 ( Fig. 1 ) have been reported in the preceding paper [5] . This report describes the physico-chemical properties and structural determination of 1, which was produced by Mechercharimyces asporophorigenens YM11-542.
Results

Physico-chemical Properties
The physico-chemical properties of 1 are summarized in Table 1 . 1 was isolated as a white solid. It was soluble in DMSO, DMF, CHCl 3 and CH 2 Cl 2 , poorly soluble in MeOH and MeCN, and insoluble in water. An analysis of lowresolution FAB-MS data in the positive and negative modes revealed its molecular mass to be 710. The molecular formula of 1 was established as C 34 The relationship of the spin networks was established from 1 H-13 C long-range correlations in the HMBC spectrum and yielded three partial structures, which were assigned to a bithiazole-benzyloxazole moiety (C 15 H 7 N 3 OS 2 , partial structure A), one oxazole (C 3 HNO, partial structure B), and an alanine and isoleucinecontaining part (C 16 H 22 N 4 O 4 , partial structure C, Fig. 2 ). The HMBC correlations when n J CH was set to 2 Hz, were observed from H-34 (d H 8.59) to C-2 (d C 135.50), and from H-6 (d H 8.88) to C-4 (d C 155.11). Consequently, C-1 of partial structure A was connected to C-2 of partial structure B, and C-4 of partial structure B was connected to C-6 of partial structure C. In addition, the ROESY correlation of H-10 (d H 1.82) and N4-H (d H 9.49) revealed that a vinylmethyl part in partial structure C had a Z configuration (Fig. 2) .
Although there is no signal between partial structure A and C in HMBC spectrum, the C-20/C-21 connection can be brought about by the comparison of the molecular formula C 34 H 30 N 8 O 6 S 2 with a tolal of each partial structures (A; C 15 H 7 N 3 OS 2 , B; C 3 HNO, C; C 16 H 22 N 4 O 4 ), enabling the planer structure of 1 to be obtained.
The absolute configuration of the alanine and isoleucine residues was determined by a Marfey analysis [6] and chiral HPLC analysis of the acid hydrolysate of 1. The Marfey analysis clarified the existence of L-Ala in the acid hydrolysate of 1, but D-Ile and D-allo-Ile were indistinguishable from the reversed-phase HPLC analysis of their FDAA derivatives. The chiral HPLC analysis successfully defined the absolute configuration of isoleucine as D-allo-Ile. Finally, the absolute stereochemistry of 1 was determined as shown in Fig. 1 .
An X-ray crystallographic analysis was also performed to confirm the full structure of 1. An adequate crystal was obtained by crystallization from CH 2 Cl 2 /MeOH (1 : 1). The crystal data and measurement conditions are summarized in the experimental section, and the ORTEP drawing shown in Fig. 3 . The absolute configuration of 1 was ascertained from an X-ray anomalous dispersion of the S atom as shown in Fig. 1 .
Discussion
The structure of 1 was determined by spectroscopic methods, chemical degradation, and by an X-ray crystallographic analysis. The structure of 1 was 257 characterized as a cyclic peptide containing L-Ala, D-alloIle and a unique bioxazole-bithiazole-phenyloxazole moiety. Compound 1 is structurally related to the 24-membered cyclic compound, including mechercharstatin isolated from another Thermoactinomycetaceae bacterium [1, 2] , YM-216391 from Streptomyces nobilis [3, 4] and telomestatin that has been isolated from Streptomyces anulatus [7] . This class of cyclic peptides containing a sequential oxazole-thiazole moiety represents a new group of antibiotics with highly potent activities. Further studies describing methods to improve the pharmaceutical properties of 1 will be reported elsewhere.
Experimental
General Procedures
Melting point (mp) values were determined with micro- , and low-and high-resolution mass spectra were measured with a JMS-SX102A instrument (Jeol). The X-ray diffraction analysis was carried out on a Mac Science (Bruker Nonius) dip image plate diffractometer, using graphite-monochromated Mo K a radiation (lϭ0.71073 Å).
Marfey Analysis
Approximately 200 mg of 1 was hydrolyzed with 500 ml of 6 N HCl at 120°C for 16 hours. The solution was freezedried and partitioned between CHCl 3 and water. The aqueous layer was then freeze-dried and used for the Marfey analysis [6] . A sample and standard amino acids (L-Ala, DL-Ala, L-Ile and DL-Ile, 2 nmol each) were dissolved in 100 ml of 0.1 N NaHCO 3 , and 50 ml of a 0.5% FDAA-acetone solution (1-fluoro-2,4-dinitrophenyl-5-Lalanineamide, Marfey's reagent, Pierce) was added. The mixture was heated at 65°C for 10 minutes, cooled to room temperature, and 50 m l of 0.2 N HCl was added. Each 100 ml of the FDAA-derived mixture was directly analyzed by HPLC. The analysis of the FDAA derivatives was performed in a TSKgel ODS-80Ts column (150ϫ4. 
Chiral HPLC Analysis
To determine the absolute configuration of Ile, another hydrolysate of 1 was prepared. Approximately 500 mg of 1 was hydrolyzed with 1.0 ml of 6 N HCl at 117°C for 15 hours. The solution was partitioned three times between ethyl acetate and water. The aqueous layer was freeze-dried and dissolved in 200 m l of water, and 50 m l of the hydrolysate was analyzed by chiral HPLC in a Sumichiral OA-5000 column (150ϫ4.6 mm, Sumika Chemical Analysis Service) maintained at 30°C with UV monitoring at 254 nm, using 5% i-propanol containing 2 mM CuSO 4 as the mobile phase at a flow rate of 1.0 ml/minute. The retention time of the acid hydrolysate of 1 was 12.32 minutes (D-allo-Ile; D-Ileϭ15.83 minutes).
X-Ray Crystal Analysis
A suitable crystal was obtained by crystallization from CH 2 Cl 2 /MeOH (1 : 1). The ORTEP drawing is shown in Fig. 3 . The absolute configuration of 1 was determined from an X-ray anomalous dispersion of the S atom as shown in Fig. 3 . The crystal used for the X-ray crystallographic analysis contained 3 molecules of CH 2 One of two molecules of urukthapelstatin A in a unit cell and co-crystallized solvent molecules are omitted for clarity.
parameters, GOFϭ1.062, and R1 (wR2)ϭ0.0639 (0.1764). The measurements were carried out by a Mac Science (Bruker Nonius) dip image plate diffractometer, using graphite-monochromated Mo K a radiation (lϭ0.71073 Å). The crystal structure was solved by the direct method with SIR-97. Refinement was performed by full-matrix leastsquares refinement on F 2 with SHELXL-97. CCDC 627198 contains supplementary crystallographic data to that presented in this paper. These data can be obtained free of charge from Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.
